Determinants of COVID-19 Vaccine Acceptance in West Papua, Indonesia

Butet Agustarika; Simon L. Momot; Alva Cherry Mustamu

doi:10.3889/oamjms.2022.8167

Authors

Butet Agustarika Department of Nursing, HealthPolytechnic of Health Ministry, Sorong, Indonesia
Simon L. Momot Department of Nursing, HealthPolytechnic of Health Ministry, Sorong, Indonesia
Alva Cherry Mustamu Department of Nursing, HealthPolytechnic of Health Ministry, Sorong, Indonesia https://orcid.org/0000-0002-6682-514X

DOI:

https://doi.org/10.3889/oamjms.2022.8167

Keywords:

COVID-19, Vaccine acceptance, Fearness

Abstract

BACKGROUND: A COVID-19 vaccine is available but acceptance in the community is still low. One of the causes of this is information, that is, lacking and cannot be understood by the community because it is not specific to the context of geography, culture, and sociodemography.

AIM: The aim of this research is to understand the people’s desire for the COVID-19 vaccine in West Papua, Indonesia.

METHODS: A web-based cross-sectional study was conducted using a snowball sampling strategy under a very limited environment. Questionnaires were designed and sent to study participants through social media forms. Study participants were recruited throughout West Papua. The main determinants predicting vaccine acceptance among respondents were modeled using logistic regression analysis.

RESULTS: A total of 314 participants were willing to take the survey. Of the 314 participants, we found that education level, knowledge, and fear were the main factors predicting acceptance of the COVID-19 vaccine, respectively (p-value; 0.019, 0.018, and 0.031).

CONCLUSIONS: Sociodemographic determinants related to COVID-19 vaccination to develop new effective interventions to increase information stability and identify key factors, health education interventions that are appropriate for the language, culture, and socioeconomics can help increase the uptake of global vaccination programs to cope with the future pandemics.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020;26:100495. https://doi.org/10.1016/j.eclinm.2020.100495 PMid:32838242 DOI: https://doi.org/10.1016/j.eclinm.2020.100495

Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Lee SS. The 2019 novel Coronavirus disease (COVID-19) pandemic: A zoonotic prospective. Asian Pac J Trop Med. 2020;13(6):242. Available from: https://www.apjtm.org/article. asp?issn=1995-7645;year=2020;volume=13;issue=6;spage=2 42;epage=246;aulast=Chakraborty;type=0 [Last accessed on 2021 Jan 11]. DOI: https://doi.org/10.4103/1995-7645.281613

Xiao X, Wong RM. Vaccine hesitancy and perceived behavioral control: A meta-analysis. Vaccine. 2020;38(33):5131-8. https://doi.org/10.1016/j.vaccine.2020.04.076 PMid:32409135 DOI: https://doi.org/10.1016/j.vaccine.2020.04.076

Gidengil CA, Parker AM, Zikmund-Fisher BJ. Trends in risk perceptions and vaccination intentions: A longitudinal study of the first year of the H1N1 pandemic. Am J Public Health. 2012;102(4):672-9. https://doi.org/10.2105/AJPH.2011.300407 PMid:22397349 DOI: https://doi.org/10.2105/AJPH.2011.300407

Habersaat KB, Jackson C. Understanding vaccine acceptance and demand-and ways to increase them. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020;63(1):32-9. https://doi.org/10.1007/s00103-019-03063-0 PMid:31802154 DOI: https://doi.org/10.1007/s00103-019-03063-0

Thunstrom L, Ashworth M, Finnoff D, Newbold S. Hesitancy Towards a COVID-19 Vaccine and Prospects for Herd Immunity, Report No. ID 3593098. Rochester, NY: Social Science Research Network; 2020. Available from: https://www.papers.ssrn.com/abstract=3593098 [Last accessed on 2021 Jan 11]. DOI: https://doi.org/10.2139/ssrn.3593098

Fu C, Wei Z, Pei S, Li S, Sun X, Liu P. Acceptance and Preference for COVID-19 Vaccination in Health-Care Workers (HCWs), medRxiv; 2020. Available from: https://www.medrxiv. org/content/10.1101/2020.04.09.20060103v1 [Last accessed on 2021 Jan 11]. DOI: https://doi.org/10.1101/2020.04.09.20060103

Kara SS, Polat M, Yayla BC, Demirdag TB, Tapisiz A, Tezer H, et al. Parental vaccine knowledge and behaviours: A survey of Turkish families. East Mediterr Health J. 2018;24(5):451-8. https://doi.org/10.26719/2018.24.5.451 PMid:30043964 DOI: https://doi.org/10.26719/2018.24.5.451

Awadh AI, Hassali MA, Al-Lela OQ, Bux SH, Elkalmi RM, Hadi H. Does an educational intervention improve parents’ knowledge about immunization? Experience from Malaysia. BMC Pediatr. 2014;14(1):254. https://doi.org/10.1186/1471-2431-14-254 PMid:25284603 DOI: https://doi.org/10.1186/1471-2431-14-254

DeRoo SS, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458-9. https://doi.org/10.1001/jama.2020.8711 PMid:32421155 DOI: https://doi.org/10.1001/jama.2020.8711

BBC. Varian Baru Virus Corona Yang Menginfeksi Anak Muda Ditemukan di Afrika Selatan, BBC News Indonesia; 2021. Available from: https://www.bbc.com/indonesia/dunia-55420197 [Last accessed on 2021 Jan 11].

Baric RS. Emergence of a highly Fit SARS-CoV-2 variant. N Engl J Med. 2020;383(27):2684-6. https://doi.org/10.1056/NEJMcibr2032888 PMid:33326716 DOI: https://doi.org/10.1056/NEJMcibr2032888

Musuamba FT, Manolis E, Holford N, Cheung SYA, Friberg LE, Ogungbenro K, et al. Advanced methods for dose and regimen finding during drug development: Summary of the EMA/EFPIA workshop on dose finding (London 4-5 December 2014). CPT Pharmacometrics Syst Pharmacol. 2017;6(7):418-29. https://doi.org/10.1002/psp4.12196 PMid:28722322 DOI: https://doi.org/10.1002/psp4.12196

Heaton PM. The COVID-19 vaccine-development multiverse. N Engl J Med. 2020;383(20):1986-8. https://doi.org/10.1056/NEJMe2025111 PMid:32663910 DOI: https://doi.org/10.1056/NEJMe2025111